PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 26, 2016Clinical Chemistry560 citationsOpen Access

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

View Full Paper
KWKai C. WollertTKTibor KempfLWLars Wallentin

Key Points

  • This research aims to evaluate GDF-15's role as a biomarker in cardiovascular disease and its potential for guiding management decisions.
  • Exploration of GDF-15 in relation to cardiovascular disease development, progression, and prognosis.
  • Comparison with clinical risk predictors and existing biomarkers.
  • GDF-15 highlights unique aspects of cardiovascular disease not captured by traditional risk predictors.
  • The study suggests further exploration of GDF-15 for management and identifying new treatment targets.

Abstract

GDF-15 captures distinct aspects of CV disease development, progression, and prognosis, which are not represented by clinical risk predictors and other biomarkers. The usefulness of GDF-15 to guide management decisions and discover new treatment targets should be further explored.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wollert et al. (2016) studied this question.

synapsesocial.com/papers/69d77f27b843b2be994900e1https://doi.org/10.1373/clinchem.2016.255174
Ask AI
Helpful
Bookmark
Share
View Full Paper